RDR03871 is a small molecule inhibitor targeting MDM2, which functions by blocking the MDM2-p53 interaction to stabilize and activate the p53 tumor suppressor pathway. It is utilized in oncology research for studying p53-mediated responses in both cellular and animal models of cancer.
Molekulargewicht:
408.81
Reinheit:
99.07% (May vary between batches)
CAS Nummer:
[286008-51-3]
Formel:
C18H16ClF3N6
Target-Kategorie:
Mdm2,MDM-2/p53
Anwendungsbeschreibung:
Solubility: DMSO:4.09 mg/mL (10 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten